Virbac SA
Virbac SA produces and sells medicines and vaccines for companion and food-producing animals in France and internationally. The company offers Boviseal, a suspension to prevent intramammary infections; Bovigen Scour, a vaccine used to protect calves against viral and bacterial infections; C.E.T. Veggiedent Fr3sh to treat oral and digestive causes of bad breath; Canigen vaccines; Clostrisan, a vaccine for the prevention of clostridiosis and botulism; Effipro bovis to treat tick, flea, and louse infestations; Epiotic, an ear cleanser; and Eradia to treat clostridium infections and giardiasis. It also provides Fosfosal, a trace mineral injectable supplementation; Grofactor, a growth promoter; Inflacalm, a multi-species anti-inflammatory; Iverhart Max Soft Chew, a chewable tablets to prevent heartworm disease; Milpro, an internal parasiticide tablets; Moxiheart, an internal parasiticide; and Multimin, a trace element injectable supplement. In addition, the company offers Suigen PCV2, a vaccine against porcine circovirus; Penclox, an antibiotic lactating intramammary targeting common bacteria causing mastitis; Physiological eye cleanser, an isotonic solution for cleaning the eye and surrounding areas; Porcistart, a feed supplement; Propofol, an anesthetic; Quadrant to treat infections; and Rabigen mono, a rabies vaccine. Further, it provides Rilexine to treat skin and urinary infections; Sentinel Flavor Tabs and Sentinel Spectrum; Shotapen for bacterial infections; Suigen PCV2, a vaccine for porcine circovirus; Suprelorin, a deslorelin-based implant for the induction of temporary infertility; Tribrissen, a parasiticide oral solution; Ultra-corn used to stimulate the immune system; Veterin, an antibiotic; Veterinary HPM, a specialized petfood; Virbagest, an altrenogest-based progestin; Virbagen Omega, a veterinary interferon; Zenifel, a fogger and spray; and Zoletil, a multi-species general anesthetic. Virbac SA was founded in 1968 and is headquartered in Carros, France. Show More...
-
Website http://corporate.virbac.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 327.00 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 7.32 6.83 7.91 7.18 7.54 1.12 4.11 -0.31 2.39 6.11 6.11 Dividends EUR 1.75 1.9 1.9 1.9 Payout Ratio % * 23.1 26.1 28.7 50.1 Shares Mil 9.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 Book Value Per Share * EUR 40.1 41.63 44.91 51.09 52.56 56.04 53.45 57.98 61.39 Free Cash Flow Per Share * EUR 6.08 1.32 3.26 3.91 6.38 9.36 7.81 9.05 Return on Assets % 13.1 10.25 9.41 7.02 5.72 0.68 2.43 -0.19 1.58 3.97 3.97 Financial Leverage (Average) 1.78 1.89 2.39 2.48 3.08 3.26 2.99 2.93 2.77 2.56 2.56 Return on Equity % 23.77 18.81 20.26 17.12 16.06 2.16 7.6 -0.57 4.48 10.54 10.54 Return on Invested Capital % 20.46 19.44 13.65 11.75 8.57 1.71 4.38 1.06 3.3 6.53 6.53 Interest Coverage 31.78 28.86 14.84 14.01 2.05 3.61 2.98 3.3 5.36 5.36 Current Ratio 1.48 1.43 1.37 1.43 1.34 1.33 1.1 1.22 1.23 1.21 1.21 Quick Ratio 0.9 0.81 0.69 0.71 0.98 0.67 0.49 0.54 0.53 0.55 0.55 Debt/Equity 0.11 0.42 0.51 0.52 1.19 0.92 0.94 0.81 0.64 0.64